Matches in Wikidata for { <http://www.wikidata.org/entity/Q94331923> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q94331923 description "wetenschappelijk artikel" @default.
- Q94331923 description "наукова стаття" @default.
- Q94331923 name "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA" @default.
- Q94331923 name "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA" @default.
- Q94331923 type Item @default.
- Q94331923 label "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA" @default.
- Q94331923 label "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA" @default.
- Q94331923 prefLabel "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA" @default.
- Q94331923 prefLabel "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA" @default.
- Q94331923 P1433 Q94331923-44AACC21-D7BD-43C1-A90F-29C9E4CD6818 @default.
- Q94331923 P1476 Q94331923-48FD3869-C3B5-4A2F-9D59-C48A98E05C16 @default.
- Q94331923 P2093 Q94331923-0795EC64-3152-4819-8FD1-BA82118E5B12 @default.
- Q94331923 P2093 Q94331923-31D368BE-A730-4CD6-A4E0-A44593AABBB7 @default.
- Q94331923 P2093 Q94331923-372D7A2F-3317-4D96-96A2-81BD415D6328 @default.
- Q94331923 P2093 Q94331923-704FDEA9-A2A9-4DFB-8BCF-D51E9CD87768 @default.
- Q94331923 P2093 Q94331923-91B84CF5-4557-4C43-A093-2C981EFD7B45 @default.
- Q94331923 P2093 Q94331923-CB6F353E-4DB1-4BAF-AA9C-9A579BF21138 @default.
- Q94331923 P2093 Q94331923-F590AAA3-E5DD-464F-AD84-79775E674E38 @default.
- Q94331923 P304 Q94331923-80D77129-A90F-493D-ABC4-CFAF73B813D0 @default.
- Q94331923 P31 Q94331923-19E38DE7-5898-43D4-A4BB-D85D799058F6 @default.
- Q94331923 P356 Q94331923-30FE6EF7-162C-44AF-8DD5-D79964EF8B29 @default.
- Q94331923 P433 Q94331923-0A8B039A-FE2C-4562-B010-15AD25E546F9 @default.
- Q94331923 P478 Q94331923-A852AF1E-DABF-4AC1-9BC0-ED55C00DF231 @default.
- Q94331923 P50 Q94331923-8E530ABA-7471-4795-8795-95BEA9DD6A3B @default.
- Q94331923 P577 Q94331923-105A125B-B446-4D4D-BC39-BBC4B8C3D9FF @default.
- Q94331923 P932 Q94331923-D2BD4FDC-2D8D-4999-BCA5-8925267BBB78 @default.
- Q94331923 P356 NOZ036.242 @default.
- Q94331923 P1433 Q15724471 @default.
- Q94331923 P1476 "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA" @default.
- Q94331923 P2093 "Claudia Petritsch" @default.
- Q94331923 P2093 "Edbert Lu" @default.
- Q94331923 P2093 "Erin Simonds" @default.
- Q94331923 P2093 "Katharina Koeck" @default.
- Q94331923 P2093 "Stefan Grossauer" @default.
- Q94331923 P2093 "Wei Wang" @default.
- Q94331923 P2093 "William Weiss" @default.
- Q94331923 P304 "ii121-ii122" @default.
- Q94331923 P31 Q13442814 @default.
- Q94331923 P356 "10.1093/NEUONC/NOZ036.242" @default.
- Q94331923 P433 "Suppl 2" @default.
- Q94331923 P478 "21" @default.
- Q94331923 P50 Q87822903 @default.
- Q94331923 P577 "2019-04-23T00:00:00Z" @default.
- Q94331923 P932 "6477238" @default.